Table 2.
Differential metabolites on day 3 TBI
| Name | MW | RT [min] | KEGGID | VIPa | p valueb | FDRc | FDRd | FC |
|---|---|---|---|---|---|---|---|---|
| Hypotaurine | 109.02 | 13.65 | C00519 | 1.07 | 1.45E−04 | 6.59E−04 | 6.59E−04 | 1.79 |
| Ornithine | 132.09 | 21.98 | C00077 | 1.08 | 1.13E−04 | 5.35E−03 | 5.34E−04 | 1.74 |
| Betaine | 117.08 | 6.17 | C00719 | 1.08 | 4.87E−05 | 2.94E−04 | 2.94E−04 | 1.70 |
| l‐Norleucine | 131.09 | 6.07 | C01933 | 1.10 | 3.44E−06 | 4.60E−05 | 4.60E−05 | 1.72 |
| 1‐Methylhistidine | 169.08 | 19.36 | C01152 | 1.13 | 1.03E−02 | 2.15E−02 | 2.15E−02 | 2.55 |
| Ascorbic acid | 176.03 | 1.75 | C00072 | 1.17 | 1.90E−04 | 8.19E−04 | 8.19E−04 | 1.99 |
| Propionylcarnitine | 217.13 | 8.27 | C03017 | 1.28 | 6.29E−05 | 3.52E−04 | 3.52E−04 | 2.17 |
| Palmitoylcarnitine | 399.33 | 2.01 | C02990 | 1.57 | 3.37E−06 | 4.58E−05 | 4.55E−05 | 2.87 |
| Adenine | 135.05 | 2.14 | C00147 | 1.58 | 6.00E−05 | 3.44E−04 | 3.44E−04 | 0.32 |
| 4‐Guanidinobutyric acid | 145.09 | 17.1 | C01035 | 1.11 | 1.26E−01 | 1.81E−01 | 1.81E−01 | 0.23 |
a
Variable importance in the projection (VIP) based on OPLS‐DA models.
b
p values were calculated by using a t test.
c
False discovery rate (FDR) was identified as <0.01.
d
Fold change (FC). Metabolites with FC > 1.5 or FC < 1 were identified.